Pathology
Predicting Cancer Relapse Improved by High-Throughput DNA Sequencing
Researchers have shown that high-throughput sequencing detects the earliest known signs of potential cancer relapse faster and in nearly twice the number of leukemia patients as flow cytometry, the current gold standard for detecting minimal residual disease. More...14 Jun 2012
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Prefilled Tubes
Prefilled 5.0ml Tubes
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
In Other News
Protein from Colonic Tissue Associated with Parkinson's
Tumor Cells Profiled by Microscopic Imaging
Techniques Compared for Bone Marrow Preparations
Rare Tumor Cells Isolated From Blood
Spinal Fluid Tests Differentiate Concurrent Brain Diseases
Oral Cancer Detection Increased with Saliva Test
Simple Blood Test Identifies Cancer from Asbestos
“Virtual Slides” Reveal Disease Tissue in 3D
Nonsurgical Test Developed For Brain Cancer
Recurring Breast Cancer Differentiated by Blood Test
Novel Biomarker Facilitates Diagnosis of Alzheimer's Disease
Genomic Test Spares Cancer Patients Chemotherapy
Potential Predictive Test Found For Alzheimer's Disease
Hematology Analyzer Evaluated for Cerebrospinal Fluid Testing
Blood Test Predicts Impending Heart Attack
Pathology Labs Replace Microscopes with Digital Imaging
Computer Trained to Evaluate Breast Cancer
Automated Microscope Alerts Diagnosticians to Possible Cell Anomalies
Liquid-Based Cytology Detects Urinary Pathogens
Regular Smear Tests Raises Chances of Cervical Cancer Cure
Cytolytic Cell Expression Predicts HIV Prognosis
Flow Cytometry Stem Cell Enumeration Kit Designed to Ease Stem Cell Transplantation
Advanced Blood Test Detects and Analyzes Circulating Tumor Cells
The Pathology channel details advances in the field of Surgical Pathology and all its subspecialties, including Cytopathology and its subspecialties.
